Author:
Mah Li-Jeen,Tortorella Stephanie,Karagiannis Tom C.
Reference181 articles.
1. Adams GP, Schier R, Mccall AM, Simmons HH, Horak EM, Alpaugh RK, Marks JD, Weiner LM (2001) High affinity restricts the localization and tumor penetration of single-chain fv antibody molecules. Cancer Res 61:4750–4755
2. Ali I, Rahis U, Salim K, Rather MA, Wani W, Haque A (2011) Advances in nano drugs for cancer chemotherapy. Curr Cancer Drug Targets 11:135–146
3. Allen TM (2002) Ligand-targeted therapeutics in anticancer therapy. Nat Rev Cancer 2:750–763
4. Badger CC, Anasetti C, Davis J, Bernstein ID (1987) Treatment of malignancy with unmodified antibody. Pathol Immunopathol Res 6:419–434
5. Baker JR (2009) Dendrimer-based nanoparticles for cancer therapy. Hematology Am Soc Hematol Educ Program 2009:708–719